Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

BIIB Biogen Inc

208,50

6,04 (2,98%)

27 Apr 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Biogen (NASDAQ:BIIB)
Historical Stock Chart
Von Mär 2024 bis Apr 2024

Click Here for more Biogen Charts.

Biogen (NASDAQ:BIIB)
Historical Stock Chart
Von Apr 2023 bis Apr 2024

Click Here for more Biogen Charts.

News Biogen Inc

Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA
Montag 1 April 2024 (4 Wochen vor) • PR Newswire (US)

New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) in Infants and Toddlers with Unmet Clinical Needs after Gene Therapy
Mittwoch 6 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024 Annual Meeting
Montag 4 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 27 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Biogen’s QALSODY® (tofersen), the First Therapy to Treat Rare, Genetic Form of ALS, Received Positive Opinion from CHMP
Freitag 23 Februar 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Donnerstag 22 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 22 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 22 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 22 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 22 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 22 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 22 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Biogen Inc News-Artikel

Deutsche Telekom

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen